## HOLX: Hologic, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 1.65 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.86)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3**
- Source: Finviz | 20251224T200814 | Bullish | Relevance: 100%
- This article reviews the Q3 earnings of several medical devices & supplies companies specializing in imaging and diagnostics. It highlights Hologic (NASDAQ:HOLX), QuidelOrtho (NASDAQ:QDEL), GE HealthCare (NASDAQ:GEHC), and Lantheus (NASDAQ:LNTH), detailing their revenue performance against analyst expectations. The industry benefits from stable demand and technological advancements but faces challenges from regulatory requirements and pricing pressures.

**2. Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3**
- Source: TradingView — Track All Markets | 20251225T030749 | Somewhat-Bullish | Relevance: 100%
- This article reviews the Q3 earnings for medical devices & supplies - imaging, diagnostics stocks, highlighting Hologic (NASDAQ:HOLX), QuidelOrtho (QDEL), GE HealthCare (GEHC), and Lantheus (LNTH). The industry faces challenges like high development costs and regulatory hurdles but benefits from consistent demand and technological advancements. Hologic showed strong revenue growth, QuidelOrtho outperformed expectations with a guidance raise, GE HealthCare had good results despite being the "weakest," and Lantheus beat analyst estimates significantly.

**3. Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open**
- Source: ts2.tech | 20251224T213810 | Somewhat-Bearish | Relevance: 100%
- Hologic stock (HOLX) experienced after-hours trading around $74.80 on Christmas Eve 2025, influenced by its pending acquisition by Blackstone and TPG for up to $79 per share, including a non-tradable Contingent Value Right (CVR). A key concern for investors is the reported difficulty in achieving the 2026 CVR milestone after Hologic stopped shipping specific breast biopsy needles. The CVR's value is directly tied to Breast Health revenue, making any product disruption a crucial factor for the market as it assesses the deal's overall value and closing conditions.

**4. Osaic Holdings Inc. Grows Position in InterDigital, Inc. $IDCC**
- Source: MarketBeat | 20251224T101304 | Neutral | Relevance: 62%
- Osaic Holdings Inc. increased its stake in InterDigital, Inc. (NASDAQ:IDCC) by 22.8% during the second quarter, bringing its total holdings to 21,245 shares valued at approximately $4.75 million. This coincides with InterDigital exceeding quarterly earnings estimates with $1.93 EPS and revenue of $164.7M and setting robust FY2025 guidance. Despite some insider selling, institutional ownership remains high, indicating strong confidence in the wireless communications provider.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.00M) |
| Sells | 26 ($6.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-2.2%)
- T. Rowe Price Invest: 9.7% (-10.5%)
- Blackrock Inc.: 8.7% (-2.7%)
- Manufacturers Life I: 4.7% (-5.2%)
- State Street Corpora: 4.5% (-1.2%)

### Key Risks

1. Insider selling cluster: $6.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.65 elevated, pricing in significant growth expectations. Balance sheet: strong liquidity (3.8x). Insider selling cluster ($6.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.6B |
| Beta | 0.70 |
| 52W Range | $51.90 - $75.34 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.65 |
| Forward P/E | 14.9 |
| Current P/E | 16.3 |
| YoY Growth | 9.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.2% to -1.4% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). RSI neutral at 49. OFD pattern: =DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.44% (CS: 33) | Neutral |
| RSI_14 | 49.2 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 1.127x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $74.50
- **Stop Loss:** $73.86 (0.9% risk)
- **Target:** $75.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 2062
- **Position Value:** $153,619.00
- **Portfolio %:** 153.62%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.10 | $1.13 | +2.7% |
| 2025Q2 | $1.05 | $1.08 | +2.7% |
| 2025Q1 | $1.02 | $1.03 | +1.4% |
| 2024Q4 | $1.02 | $1.03 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*